Oxford, United Kingdom

John D Priddle

This inventor holds 1 USPTO granted patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John D Priddle. Retrieved from https://idiyas.com/inventor/john-d-priddle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John D. Priddle

Introduction

John D. Priddle is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical diagnostics, particularly in relation to Alzheimer's disease. His innovative approach has led to the development of a method that aids in the early detection of senile dementia.

Latest Patents

John D. Priddle holds a patent for a method of diagnosing senile dementia of the Alzheimer type. This method involves testing for an anomalous molecular form of acetylcholinesterase in the cerebrospinal fluid of a patient. This breakthrough has the potential to enhance the accuracy of Alzheimer's disease diagnosis.

Career Highlights

Priddle is associated with E. R. Squibb Sons, Inc., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of neurodegenerative diseases. He has dedicated his career to improving diagnostic methods that can lead to better patient outcomes.

Collaborations

Throughout his career, John D. Priddle has collaborated with esteemed colleagues such as Dasakumar S. Navaratnam and Brendon I. McDonald. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

John D. Priddle's contributions to the field of Alzheimer's diagnostics exemplify the impact of innovative thinking in medicine. His work continues to inspire advancements in the diagnosis and treatment of neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…